|
GB0012528D0
(en)
*
|
2000-05-23 |
2000-07-12 |
Univ Palackeho |
Triterpenoid derivatives
|
|
GB0219052D0
(en)
*
|
2002-08-15 |
2002-09-25 |
Cyclacel Ltd |
New puring derivatives
|
|
GB0226583D0
(en)
*
|
2002-11-14 |
2002-12-18 |
Cyclacel Ltd |
Compounds
|
|
GB0229581D0
(en)
*
|
2002-12-19 |
2003-01-22 |
Cyclacel Ltd |
Use
|
|
CN1897950A
(zh)
|
2003-10-14 |
2007-01-17 |
惠氏公司 |
稠合芳基和杂芳基衍生物及其使用方法
|
|
AU2005293607A1
(en)
|
2004-10-07 |
2006-04-20 |
Boehringer Ingelheim International Gmbh |
PI3 kinases
|
|
US7713973B2
(en)
|
2004-10-15 |
2010-05-11 |
Takeda Pharmaceutical Company Limited |
Kinase inhibitors
|
|
EP2275095A3
(en)
|
2005-08-26 |
2011-08-17 |
Braincells, Inc. |
Neurogenesis by muscarinic receptor modulation
|
|
EP2258359A3
(en)
|
2005-08-26 |
2011-04-06 |
Braincells, Inc. |
Neurogenesis by muscarinic receptor modulation with sabcomelin
|
|
DE102005048072A1
(de)
*
|
2005-09-24 |
2007-04-05 |
Bayer Cropscience Ag |
Thiazole als Fungizide
|
|
US8119655B2
(en)
|
2005-10-07 |
2012-02-21 |
Takeda Pharmaceutical Company Limited |
Kinase inhibitors
|
|
EP2377530A3
(en)
|
2005-10-21 |
2012-06-20 |
Braincells, Inc. |
Modulation of neurogenesis by PDE inhibition
|
|
EP2314289A1
(en)
|
2005-10-31 |
2011-04-27 |
Braincells, Inc. |
Gaba receptor mediated modulation of neurogenesis
|
|
DE102006001161A1
(de)
*
|
2006-01-06 |
2007-07-12 |
Qiagen Gmbh |
Verfahren zum Nachweis von Cytosin-Methylierungen
|
|
US20100216734A1
(en)
|
2006-03-08 |
2010-08-26 |
Braincells, Inc. |
Modulation of neurogenesis by nootropic agents
|
|
US20070238746A1
(en)
*
|
2006-04-06 |
2007-10-11 |
Trixi Brandl |
Thiazolyl-dihydro-chinazoline
|
|
US7517995B2
(en)
|
2006-04-06 |
2009-04-14 |
Boehringer Ingelheim International Gmbh |
Thiazolyl-dihydro-cyclopentapyrazole
|
|
US7691868B2
(en)
|
2006-04-06 |
2010-04-06 |
Boehringer Ingelheim International Gmbh |
Thiazolyl-dihydro-quinazoline
|
|
JP5313875B2
(ja)
*
|
2006-04-12 |
2013-10-09 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
増殖性疾患の処置のためのタンパク質キナーゼｐｌｋ１の阻害剤として有用な４，５−ジヒドロ−［１，２，４］トリアゾロ［４，３−ｆ］プテリジン
|
|
CA2651813A1
(en)
|
2006-05-09 |
2007-11-22 |
Braincells, Inc. |
Neurogenesis by modulating angiotensin
|
|
US20100184806A1
(en)
|
2006-09-19 |
2010-07-22 |
Braincells, Inc. |
Modulation of neurogenesis by ppar agents
|
|
US8779154B2
(en)
|
2006-09-26 |
2014-07-15 |
Qinglin Che |
Fused ring compounds for inflammation and immune-related uses
|
|
US20100120717A1
(en)
|
2006-10-09 |
2010-05-13 |
Brown Jason W |
Kinase inhibitors
|
|
CN104151293A
(zh)
|
2007-10-12 |
2014-11-19 |
阿斯利康公司 |
蛋白激酶抑制剂
|
|
EP2100894A1
(en)
|
2008-03-12 |
2009-09-16 |
4Sc Ag |
Pyridopyrimidines used as Plk1 (polo-like kinase) inhibitors
|
|
CA2719538C
(en)
*
|
2008-04-07 |
2014-03-18 |
Amgen Inc. |
Gem-disubstituted and spirocyclic amino pyridines/pyrimidines as cell cycle inhibitors
|
|
JP5579724B2
(ja)
*
|
2008-10-17 |
2014-08-27 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
ホスファチジルイノシトール−３−キナーゼ（ｐｉ−３キナーゼ）阻害剤としてのテトラ−アザ−複素環
|
|
US20100216805A1
(en)
|
2009-02-25 |
2010-08-26 |
Braincells, Inc. |
Modulation of neurogenesis using d-cycloserine combinations
|
|
MX2012000178A
(es)
|
2009-07-02 |
2012-02-28 |
Novartis Ag |
2-carboxamida-cicloamino-ureas utiles como inhibidores de pi3k.
|
|
JP2013521324A
(ja)
|
2010-03-10 |
2013-06-10 |
インゲニウム ファーマシューティカルズ ジーエムビーエイチ |
プロテインキナーゼの阻害剤
|
|
WO2013059634A1
(en)
|
2011-10-20 |
2013-04-25 |
The Regents Of The University Of California |
Use of cdk9 inhibitors to reduce cartilage degradation
|
|
EP3206749B1
(en)
|
2014-10-14 |
2021-09-08 |
The Regents of the University of California |
The cdk9 and brd4 inhibitors flavopiridol and jq1 to inhibit cartilage inflammation
|
|
US20170283445A1
(en)
|
2016-04-05 |
2017-10-05 |
University Of South Carolina |
Small Molecule Inhibitors Selective For Polo-Like Kinase Proteins
|
|
CN109803972B
(zh)
*
|
2017-04-01 |
2021-11-23 |
晟科药业（江苏）有限公司 |
1h-咪唑[4,5-h]喹唑啉类化合物作为蛋白激酶抑制剂
|
|
US11319323B2
(en)
|
2017-08-11 |
2022-05-03 |
Shengke Pharmaceuticals (Jiangsu) Ltd. |
Substituted pyrazolo[4,3-H]quinazolines as protein kinase inhibitors
|
|
US11162083B2
(en)
|
2018-06-14 |
2021-11-02 |
University Of South Carolina |
Peptide based inhibitors of Raf kinase protein dimerization and kinase activity
|
|
US11066404B2
(en)
|
2018-10-11 |
2021-07-20 |
Incyte Corporation |
Dihydropyrido[2,3-d]pyrimidinone compounds as CDK2 inhibitors
|
|
WO2020168197A1
(en)
|
2019-02-15 |
2020-08-20 |
Incyte Corporation |
Pyrrolo[2,3-d]pyrimidinone compounds as cdk2 inhibitors
|
|
TW202100520A
(zh)
|
2019-03-05 |
2021-01-01 |
美商英塞特公司 |
作為cdk2 抑制劑之吡唑基嘧啶基胺化合物
|
|
US11919904B2
(en)
|
2019-03-29 |
2024-03-05 |
Incyte Corporation |
Sulfonylamide compounds as CDK2 inhibitors
|
|
WO2020223558A1
(en)
|
2019-05-01 |
2020-11-05 |
Incyte Corporation |
Tricyclic amine compounds as cdk2 inhibitors
|
|
US11440914B2
(en)
|
2019-05-01 |
2022-09-13 |
Incyte Corporation |
Tricyclic amine compounds as CDK2 inhibitors
|
|
CN114174301B
(zh)
*
|
2019-08-02 |
2024-03-15 |
成都赛璟生物医药科技有限公司 |
1h-[1,2,3]三唑并[4,5-h]喹唑啉类化合物作为蛋白激酶抑制剂
|
|
EP4013750A1
(en)
|
2019-08-14 |
2022-06-22 |
Incyte Corporation |
Imidazolyl pyrimidinylamine compounds as cdk2 inhibitors
|
|
WO2021072232A1
(en)
|
2019-10-11 |
2021-04-15 |
Incyte Corporation |
Bicyclic amines as cdk2 inhibitors
|
|
CN116601155A
(zh)
*
|
2020-11-26 |
2023-08-15 |
成都赛璟生物医药科技有限公司 |
杂芳基并喹唑啉类化合物作为蛋白激酶抑制剂
|
|
US11981671B2
(en)
|
2021-06-21 |
2024-05-14 |
Incyte Corporation |
Bicyclic pyrazolyl amines as CDK2 inhibitors
|
|
US11976073B2
(en)
|
2021-12-10 |
2024-05-07 |
Incyte Corporation |
Bicyclic amines as CDK2 inhibitors
|
